Back
Haleon PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
86
HLN
Haleon PLC
Last Price:
10.56
Seasonality Move:
15.78%
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.03
Seasonality Move:
-31.44%
Buy
86
Haleon PLC (HLN)
is a Buy
Is Haleon PLC a Buy, Sell or Hold?
- The current Haleon PLC [HLN] share price is $10.65. The Score for HLN is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- HLN is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.05. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HLN Stock Price Chart
What is Haleon PLC's stock price today?
-
The Haleon PLC share price today is $10.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HLN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
HLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 80.11 | Buy |
| Chaikin Money Flow: | 2020610 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.82 - 10.42) | Buy |
| Bollinger Bands (100): | (8.28 - 9.76) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.65 | Sell |
| Chaikin Money Flow: | -574860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.22) | Sell |
| Bollinger Bands (100): | (1 - 1.22) | Sell |
HLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.48 | Buy |
| 20-day SMA: | 10.21 | Buy |
| 50-day SMA: | 9.63 | Buy |
| 200-day SMA: | 8.66 | Buy |
| 8-day EMA: | 10.48 | Buy |
| 20-day EMA: | 10.23 | Buy |
| 50-day EMA: | 9.74 | Buy |
| 200-day EMA: | 8.85 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.17 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.12 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.1 | Sell |
Haleon PLC Earnings Growth & HLN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.04 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Haleon PLC Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||